[Webinar] Manufacturing concepts for antibody-drug conjugates

The antibody-drug conjugate (ADC) market is witnessing rapid growth due to increased demand for targeted cancer therapies and improved conjugation technologies. Watch our STAT webinar to gain insights on the latest ADC advancements and discover the critical role CDMOs play in ensuring safe and efficient manufacturing processes. ⏱️ Chapters: 0:00 Who is presenting? 1:43 How did ADCs get to where they are? 4:58 What are the parts of an ADC? 7:59 How does ADC conjugation run in the facility? 12:35 Which analytical methods support ADC release? 15:36 How is ADC safety risk assessed? 21:30 How are containment and the control matrix applied? 24:28 What should a CDMO manage besides safety? 26:59 Why did Samsung Biologics build a new ADC facility? #SamsungBiologics #ADCs #CDMO #Bioconjugate #HPAPI